Author:
Hiatt Robert A.,Sibley Amanda,Venkatesh Brinda,Cheng Joyce,Dixit Niharika,Fox Rena,Ling Pamela,Nguyen Tung,Oh Debora,Palmer Nynikka R.,Pasick Rena J.,Potter Michael B.,Somsouk Ma,Vargas Roberto Ariel,Vijayaraghavan Maya,Ashworth Alan
Abstract
Abstract
Purpose of Review
Cancer incidence and mortality are decreasing, but inequities in outcomes persist. This paper describes the San Francisco Cancer Initiative (SF CAN) as a model for the systematic application of epidemiological evidence to reduce the cancer burden and associated inequities.
Recent Findings
SF CAN is a multi-institutional implementation of existing evidence on the prevention and early detection of five common cancers (i.e., breast, prostate, colorectal, liver, and lung/tobacco-related cancers) accounting for 50% of cancer deaths in San Francisco. Five Task Forces follow individual logic models designating inputs, outputs, and outcomes. We describe the progress made and the challenges faced by each Task Force after 5 years of activity.
Summary
SF CAN is a model for how the nation’s Comprehensive Cancer Centers are ideally positioned to leverage cancer epidemiology for evidence-based initiatives that, along with genuine community engagement and multiple stakeholders, can reduce the population burden of cancer.
Publisher
Springer Science and Business Media LLC
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献